A detailed history of New South Capital Management Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, New South Capital Management Inc holds 7,189 shares of BMY stock, worth $414,445. This represents 0.02% of its overall portfolio holdings.

Number of Shares
7,189
Previous 7,189 -0.0%
Holding current value
$414,445
Previous $298,000 24.83%
% of portfolio
0.02%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 13, 2020

SELL
$57.43 - $63.64 $64,493 - $71,467
-1,123 Reduced 13.51%
7,189 $433,000
Q3 2017

Nov 13, 2017

BUY
$55.23 - $63.74 $459,071 - $529,806
8,312
8,312 $530,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track New South Capital Management Inc Portfolio

Follow New South Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New South Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on New South Capital Management Inc with notifications on news.